BGI Genomics Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 821.25 million compared to CNY 954.89 million a year ago. Revenue was CNY 821.25 million compared to CNY 954.89 million a year ago.

Net income was CNY 12.4 million compared to CNY 41.21 million a year ago. Basic earnings per share from continuing operations was CNY 0.0303 compared to CNY 0.0908 a year ago. Diluted earnings per share from continuing operations was CNY 0.0302.